Chemistry:Perphenazine enanthate

From HandWiki
Short description: Typical antipsychotic medication
Perphenazine enanthate
Perphenazine enanthate.svg
Clinical data
Trade namesDecentan Depot, Peratsin Enantaatti, Trilafon, Trilafon Enantato, Trilafon Enantat, Trilifan Retard
Other namesPerphenazine enantate
Routes of
administration
Intramuscular injection
Drug classTypical antipsychotic
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC28H38ClN3O2S
Molar mass516.14 g·mol−1
3D model (JSmol)

Perphenazine enanthate, sold under the brand name Trilafon Enantat among others, is a typical antipsychotic and a depot antipsychotic ester which is used in the treatment of schizophrenia and has been marketed in Europe.[1][2][3][4][5][6] It is formulated in sesame oil and administered by intramuscular injection and acts as a long-lasting prodrug of perphenazine.[2][3][4][5][6] Perphenazine enanthate is used at a dose of 25 to 200 mg once every 2 weeks by injection, with a time to peak levels of 2 to 3 days and an elimination half-life of 4 to 7 days.[2][3][4][5][6]


See also

References

  1. Swiss Pharmaceutical Society (2000). Swiss Pharmaceutical Society. ed. Index Nominum 2000: International Drug Directory. Taylor & Francis. pp. 811–. ISBN 978-3-88763-075-1. https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA811. 
  2. 2.0 2.1 2.2 "Intramuscular preparations of antipsychotics: uses and relevance in clinical practice". Drugs 63 (5): 493–512. 2003. doi:10.2165/00003495-200363050-00004. PMID 12600227. 
  3. 3.0 3.1 3.2 "Depot antipsychotic drugs. Place in therapy". Drugs 47 (5): 741–73. May 1994. doi:10.2165/00003495-199447050-00004. PMID 7520856. 
  4. 4.0 4.1 4.2 "Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review". Br J Psychiatry Suppl 52: S13–9. November 2009. doi:10.1192/bjp.195.52.s13. PMID 19880912. 
  5. 5.0 5.1 5.2 "The pharmacokinetics of long-acting antipsychotic medications". Curr Clin Pharmacol 9 (3): 310–7. 2014. doi:10.2174/15748847113089990051. PMID 23343447. 
  6. 6.0 6.1 6.2 "History and therapeutic rationale of long acting antipsychotics". Curr Clin Pharmacol 9 (1): 39–52. February 2014. doi:10.2174/15748847113089990057. PMID 23343446.